Apoptosis in Biological Technology
Navigation Links
Apoptosis in Biological Technology
... Therapeutics
Preclinical Mechanism apoptosis in CLL Cells Occurs Via Distinct Mechanism ... study evaluating the effect of TRU-016 on direct apoptosis in CLL cells.
(Logo: ... Modular ImmunoPharmaceutical (SMIP) on direct apoptosis in chronic lymphocytic leukemia cells via ...
... and anti-inflammatory activities by inducing apoptosis in T-cell derived tumors and blocking IL-1B ... levels of reactive oxygen species, induces apoptosis and inhibits NFkB in leukemia models Abstract ... Oral presentation: Multiple mechanisms of apoptosis induction by the histone deacetylase ...
... exciting small-molecule drugs that also enhance apoptosis in cancer cells. We look forward to developing ... a Small Molecule IAP Inhibitor Activation of apoptosis (programmed cell death) in cancer cells is a key ... of apoptosis) family are important regulators of apoptosis in cancer cells. A growing body of evidence ...
... pathway utilizing EpiCept's Anti-cancer Screening apoptosis Platform (ASAP). (Logo: ... utilized the cell- and caspase-based apoptosis induction assay for both discovery and successive ... programmed cell death, which is called apoptosis. apoptosis is normally triggered to destroy a cell from ...
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...
... Bcl-2, Bcl-xL, Bcl-w, and Mcl-1 inhibition) that has been shown to induce apoptosis directly by operating as a BH3 mimetic and indirectly as an independent ... factors, AT-101 lowers the threshold for cancer cells to undergo apoptosis in various tumor types. About Ascenta Therapeutics Ascenta ...
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...
... with unique mechanisms of inhibiting the growth and causing apoptosis (programmed cell death) of malignant cells. Previously, ONCONASE has been ... of this action was shown to be the triggering of caspase-dependent apoptosis by activation of the mitochondrial pathway. The combination of ONCONASE or ...
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases inflammatory and ischemic ...
... of intracellular cysteine proteases that are vital in the process of apoptosis (programmed cell death). Caspase-3 functions as the most downstream ... results in the final execution of cell death. Insufficient or accelerated apoptosis is implicated in a variety of diseases such as cancer, immune system ...
... the initiation of a Phase 1 clinical trial of the IAP ("Inhibitor of apoptosis Protein") inhibitor, HGS1029 (formerly AEG40826), as a monotherapy in ... stage biotechnology company focused on developing drugs that control apoptosis to address major unmet medical needs. In addition to HGS1029 (AEG40826), ...
... channels. In addition, ANAVEX 7-1037 has been shown to induce selective apoptosis (programmed cell death) in HCT116 colon cancer cells in vitro, as detailed ... with apoptosis. Sigma-2 receptor agonists are reported to induce apoptosis by a novel mechanism, exhibiting similar potency in tumors with wild-type ...
... one another and in combination with other therapies. "The TRAIL-mediated apoptosis pathway is an exciting area of cancer research, and agonistic antibodies ... by adding small-molecule drugs known as IAP inhibitors, which also enhance apoptosis in cancer cells. We look forward to developing our TRAIL receptor ...
... a new class of selective, irreversible proteasome inhibitors. Carfilzomib produces specific and sustained inhibition of the proteasome, leading to apoptosis in cancer cells with minimal off-target effects. In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in ...
... as such, acts as a key regulator of cellular energetics. Endogenous adenosine protects cells from multiple pathways of injury such as inflammation, apoptosis and necrosis. Endogenous adenosine levels have been shown to be elevated in heart failure patients but not sufficiently to be cardioprotective. ...
... of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following both oral and intravenous ...
... was presented yesterday: Abstract 2822: Evidence implicating Bim activation/induction in potentiation of PI3K/Akt inhibitor-mediated apoptosis in human leukemia cells Author(s): Mohamed Rahmani, Anh Anderson, Joseph Reza Habibi, Timothy Ryan Crabtree, Hisashi Harada, Paul Dent, Steven ...
... works via several mechanisms of action: (1) targeting select kinases that are altered in human cancers; (2) inhibiting angiogenesis; and (3) inducing apoptosis (programmed cell death). When evaluated against other oral, commercially available, targeted agents, ACTB1003 demonstrated greater anti-tumor ...
... tumor cell types (prostate, lung, ovary, colon, CNS, melanoma, and hematopoietic lineages) by disruption of cell cycle progression and induction of apoptosis with a secondary anti-angiogenic activity as a consequence of the cytoskeletal disruption. The unique activity, novel structure, potent in vivo ...
First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418
... I (GGTase I) that induces apoptosis by downregulating several pivotal oncogenic and ... inhibitor of GGTase I that appears to induce apoptosis by downregulating several pivotal oncogenic and ... suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the ...Telik Reports Preclinical Results at AACR Annual Meeting
... Aurora kinase activity induces growth arrest and apoptosis in cells and leads to tumor-growth inhibition in ... compounds induced growth arrest, polyploidy and apoptosis in human cancer cell lines, such as HCT116 ... in human solid tumor cell lines. The resulting apoptosis or senescence of these cells may depend on their ...Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models
... the activity of at least three "inhibitors of apoptosis proteins" or IAPs (including XIAP, c-IAP1, and c-IAP2) to create conditions in which apoptosis can proceed. As such, AT-406 is considered a ... degradation of cIAP-1/2 proteins and promotes apoptosis through activation of caspase-8 and the ...FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
... I (GGTase I) that induces apoptosis by downregulating several pivotal oncogenic and ... inhibitor of GGTase I that appears to induce apoptosis by downregulating several pivotal oncogenic and ... suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the ...Tigris Pharmaceuticals Files IND Application for GGTI-2418
... I (GGTase I) that appears to induce apoptosis by downregulating several pivotal oncogenic and ... I (GGTase I) that appears to induce apoptosis by downregulating several pivotal oncogenic and ... suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the ...... and anti-inflammatory activities by inducing apoptosis in T-cell derived tumors and blocking IL-1B ... levels of reactive oxygen species, induces apoptosis and inhibits NFkB in leukemia models Abstract ... Oral presentation: Multiple mechanisms of apoptosis induction by the histone deacetylase ...
... exciting small-molecule drugs that also enhance apoptosis in cancer cells. We look forward to developing ... a Small Molecule IAP Inhibitor Activation of apoptosis (programmed cell death) in cancer cells is a key ... of apoptosis) family are important regulators of apoptosis in cancer cells. A growing body of evidence ...
... pathway utilizing EpiCept's Anti-cancer Screening apoptosis Platform (ASAP). (Logo: ... utilized the cell- and caspase-based apoptosis induction assay for both discovery and successive ... programmed cell death, which is called apoptosis. apoptosis is normally triggered to destroy a cell from ...
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
... through EpiCept's Anti-cancer Screening apoptosis Program (ASAP). EPC2407, a novel small molecule vascular disruption agent and apoptosis inducer for the treatment of cancer patients with ... programmed cell death, which is called apoptosis. apoptosis is normally triggered to destroy a cell from ...Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...ArborGen and Senesco Announce Wood Quality Results
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...
... Bcl-2, Bcl-xL, Bcl-w, and Mcl-1 inhibition) that has been shown to induce apoptosis directly by operating as a BH3 mimetic and indirectly as an independent ... factors, AT-101 lowers the threshold for cancer cells to undergo apoptosis in various tumor types. About Ascenta Therapeutics Ascenta ...
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...
Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. ...Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases such as glaucoma, ischemia and ...... with unique mechanisms of inhibiting the growth and causing apoptosis (programmed cell death) of malignant cells. Previously, ONCONASE has been ... of this action was shown to be the triggering of caspase-dependent apoptosis by activation of the mitochondrial pathway. The combination of ONCONASE or ...
... determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases inflammatory and ischemic ...
... of intracellular cysteine proteases that are vital in the process of apoptosis (programmed cell death). Caspase-3 functions as the most downstream ... results in the final execution of cell death. Insufficient or accelerated apoptosis is implicated in a variety of diseases such as cancer, immune system ...
Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
... and drug development company, leading the translation of the science of apoptosis (programmed cell death) into clinical practice. Aposense introduces novel ... identify and accumulate within apoptotic (dying) cells in vivo. apoptosis plays a role in many diseases across numerous clinical areas, including ...Oncothyreon announces prioritization plan for development programs
... cell death). Preclinical data have demonstrated that PX-478 can induce apoptosis in experimental tumor models, as well as the down-regulation of factors ... and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged ...SuperGen Reports 2008 Second Quarter Financial Results
... as a potent and selective inhibitor of the PIM kinases, inducing apoptosis and cell cycle arrest, thereby causing a reduction in phospho-BAD ... the PIM kinases. SGI-1776 induces cell cycle arrest, dose dependent apoptosis and a reduction in phospho-BAD levels in leukemia and lymphoma cell ...Senesco Technologies to Present at BIO 2008 Business Forum
... determine if its technology is applicable in human medicine. Accelerating apoptosis may have applications to the development of cancer treatments. Delaying apoptosis may have applications to certain diseases such as glaucoma, ischemia and ...... the initiation of a Phase 1 clinical trial of the IAP ("Inhibitor of apoptosis Protein") inhibitor, HGS1029 (formerly AEG40826), as a monotherapy in ... stage biotechnology company focused on developing drugs that control apoptosis to address major unmet medical needs. In addition to HGS1029 (AEG40826), ...
Human Genome Sciences Advances Oncology Portfolio
... are building our oncology portfolio around our leading expertise in the apoptosis pathway. We have added IAP inhibitors, which are highly complementary to ... is the most advanced of any product in development that targets the TRAIL apoptosis pathway. HGS has advanced HGS-ETR1 to a proof-of-concept phase consisting ...ARIUS presents new findings for anti-cancer antibody programs at AACR
... that treatment with ARIUS' CD9 targeting antibody, AR40A746.2.3, induced apoptosis in BxPC-3 pancreatic cancer cell as a monotherapy. Moreover, apoptosis is achieved through inhibition of the AKT pathway, commonly believed to be ...... channels. In addition, ANAVEX 7-1037 has been shown to induce selective apoptosis (programmed cell death) in HCT116 colon cancer cells in vitro, as detailed ... with apoptosis. Sigma-2 receptor agonists are reported to induce apoptosis by a novel mechanism, exhibiting similar potency in tumors with wild-type ...
Oncothyreon's PX-478 is effective in preclinical model of human lung cancer
... growth (angiogenesis), use of glucose for energy, and protection against apoptosis (programmed cell death). Preclinical data have demonstrated that PX-478 can induce apoptosis in experimental tumor models, as well as the down-regulation of factors ...... one another and in combination with other therapies. "The TRAIL-mediated apoptosis pathway is an exciting area of cancer research, and agonistic antibodies ... by adding small-molecule drugs known as IAP inhibitors, which also enhance apoptosis in cancer cells. We look forward to developing our TRAIL receptor ...
... a new class of selective, irreversible proteasome inhibitors. Carfilzomib produces specific and sustained inhibition of the proteasome, leading to apoptosis in cancer cells with minimal off-target effects. In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in ...
... as such, acts as a key regulator of cellular energetics. Endogenous adenosine protects cells from multiple pathways of injury such as inflammation, apoptosis and necrosis. Endogenous adenosine levels have been shown to be elevated in heart failure patients but not sufficiently to be cardioprotective. ...
... of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following both oral and intravenous ...
Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
... of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following both oral and intravenous ...Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting
... a new class of selective, irreversible proteasome inhibitors. Carfilzomib produces specific and sustained inhibition of the proteasome, leading to apoptosis in cancer cells with minimal off-target effects. In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in ...Sigma-Aldrich Introduces Precisio(TM) Kinases for High-Throughput Screening and Kinase Profiling
... kinases are essential in intercellular communication, mediating signal transduction in development, transcription, immune response, metabolism, apoptosis and cell differentiation. Improper kinase function plays a role in many diseases, most notably cancer, and the study of these proteins and their ...... was presented yesterday: Abstract 2822: Evidence implicating Bim activation/induction in potentiation of PI3K/Akt inhibitor-mediated apoptosis in human leukemia cells Author(s): Mohamed Rahmani, Anh Anderson, Joseph Reza Habibi, Timothy Ryan Crabtree, Hisashi Harada, Paul Dent, Steven ...
... works via several mechanisms of action: (1) targeting select kinases that are altered in human cancers; (2) inhibiting angiogenesis; and (3) inducing apoptosis (programmed cell death). When evaluated against other oral, commercially available, targeted agents, ACTB1003 demonstrated greater anti-tumor ...
... tumor cell types (prostate, lung, ovary, colon, CNS, melanoma, and hematopoietic lineages) by disruption of cell cycle progression and induction of apoptosis with a secondary anti-angiogenic activity as a consequence of the cytoskeletal disruption. The unique activity, novel structure, potent in vivo ...
Other ContentsoriginoriginoriginoriginoriginoriginoriginoriginosmosisosmosisosmosisaveryoutbreakoutbreakoutbreakoutbreakoutbreakoutbreakoxidativeoxidativeoxidativeoxidativeoxidativeoxidativeoxidativeoxidativepaleontologypaleontologyparallelparallelparallelparallelparallelparallelparallelparallelparallelOther TagsodorflusLangeOther Tagsrestaurants 2restaurants 3restaurants 4restaurants 5restaurants 6function 2function 3function 4function 5function 6function 7function 8function 9function 10damages 2permanently 2permanently 3nutrition 2nutrition 3prenatal 2poor 2poor 3poor 4poor 5poor 6poor 7poor 8poor 9poor 10
(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ath Research Laboratory in the University of Haifa...stigious Johnson & Johnson Focused Funding grant f...damage in Parkinson,s disease. The award, which is...ovation and excellence in science, was announced i...h at an event at the Hyatt Regency Hotel in New Je...
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Celebrate June Is Dairy Month Beginning With Breakfast 48128 1Celebrate June Is Dairy Month Beginning With Breakfast 48128 2Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 1Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 1Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 3Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 4Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 5Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 6Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 7Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 8(Date:11/30/2009)... Firm uses Staten Island courtroom to recreate ...were 100% responsible for client’s accident.... November 30, 2009 -- A Staten Island, N.Y. jury a...aperhanger who was injured at a New York City cons... J.T. Magen Construction Company et al (Index No. ...
(Date:11/30/2009)...ELAND, Ohio, November 30 Simbionix... medical simulation systems, in collaboration,with...e Rehearsal Studio(TM),workshop for the first time...y. , The Simbionix PROcedure Rehearsal St... enable clinicians to create practice scenarios ba...
(Date:11/30/2009)...y is an effective, convenient technique that, when...cerous breast lesions from benign results, accordi...al meeting of the Radiological Society of North Am...us findings, physicians often use ultrasound to ob...as the potential to result in more biopsies becaus...
(Date:11/29/2009)... The Academy of General Dentistry (AGD) announc...eived the Mastership Award during the AGD,s commen...mmitment to excellence in dental education.,To ac... approved continuing dental education in the 16 di...ted to hands-on skills and techniques. , ...
(Date:11/29/2009)...00 round of treatment equals a $41,000 pay raise, ...ealthDay News) -- Psychological therapy may be muc...ng a raise or winning a lottery prize, suggests an...thousands of people who provided information about...se in happiness from a $1,329 course of therapy wa...
Breaking Medicine News(10 mins):Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2[0] Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident[0] Simbionix First Procedure Rehearsal Studio(TM) Training Workshop[0] Elastography reduces unnecessary breast biopsies[1] Orange County Dentist Honored by The Academy of General Dentistry [0] Psychotherapy Can Boost Happiness More Than Money: Study
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |